PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 12, 2017Clinical Chemistry and Laboratory Medicine (CCLM)33 citations

Analytical evaluation of the new Beckman Coulter Access high sensitivity cardiac troponin I immunoassay

View Full Paper
GLGiuseppe LippiAFAnna FerrariGGGiorgio Gandini

Key Result

The Beckman Coulter Access hsTnI assay demonstrated excellent analytical performance, with a 99th percentile URL of 15.8 ng/L and measurable cTnI values in 98.9% of healthy subjects.

Study Design

Type

Cross-Sectional (n=175)

Structured PICO

Does the Beckman Coulter Access hsTnI immunoassay provide reliable analytical performance for measuring cardiac troponin I compared to existing commercial assays?

P
Population
175 healthy blood donors (mean age 36 years, 47% women) evaluated to establish the 99th percentile upper reference limit for a novel hsTnI assay.
E
Exposure
Beckman Coulter Access hsTnI high-sensitivity immunoassay
C
Comparator
AccuTnI+3 and Siemens Dimension Vista cTnI immunoassays
O
Outcome
Analytical performance including limit of blank, limit of detection, functional sensitivity, linearity, imprecision, and 99th percentile upper reference limitsurrogate

The novel Beckman Coulter Access hsTnI immunoassay demonstrates excellent analytical performance and high sensitivity for measuring cardiac troponin I.

Abstract

BACKGROUND: This study was aimed to evaluate the analytical performance of the novel chemiluminescent and fully-automated Beckman Coulter Access hsTnI high-sensitivity immunoassay for measurement of cardiac troponin I (cTnI). METHODS: The study, using lithium heparin samples, included assessment of limit of blank (LOB), limit of detection (LOD), functional sensitivity, linearity, imprecision (within run, between-run and total), calculation of 99th percentile upper reference limit (URL) in 175 healthy blood donors (mean age, 36±12 years; 47% women) and comparison with two other commercial cTnI immunoassays. RESULTS: The LOB, LOD and functional sensitivity of Access hsTnI were 0.14, 0.34 and 1.35 ng/L, respectively. The within-run, between-run and total imprecision was 2.2%-2.9%, 4.6%-5.4%, and 5.4%-6.1%, respectively. The linearity was excellent in the range of cTnI values between 0.95 and 4195 ng/L (r=1.00). The 99th percentile URL was 15.8 ng/L. Measurable cTnI values were found in 173/175 healthy subjects (98.9%). Good agreement of cTnI values was found with AccuTnI+3 (r=0.97; mean bias, -9.3%), whereas less satisfactory agreement was found with Siemens Dimension Vista cTnI (r=0.95; mean bias, -55%). CONCLUSIONS: The results of our evaluation of the Beckman Coulter Access hsTnI indicate that the analytical performance of this fully-automated immunoassay is excellent.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lippi et al. (2017) conducted a cross-sectional in Healthy (n=175). Beckman Coulter Access hsTnI high-sensitivity immunoassay vs. AccuTnI+3 and Siemens Dimension Vista cTnI was evaluated on Analytical performance including limit of blank, limit of detection, functional sensitivity, imprecision, linearity, and 99th percentile URL. The Beckman Coulter Access hsTnI assay demonstrated excellent analytical performance, with a 99th percentile URL of 15.8 ng/L and measurable cTnI values in 98.9% of healthy subjects.

synapsesocial.com/papers/6a2197f3cdf8429e7e5fd7c5https://doi.org/10.1515/cclm-2017-0350
Ask AI
Helpful
Bookmark
Share
View Full Paper